Product name | Recombinant SARS-CoV-2 papain-like protease Protein |
---|---|
Catalog No. | RP01274LQ |
Description | Recombinant SARS-CoV-2(2019-nCoV) papain-like protease is produced by E. coli expression system. The target protein is expressed with sequence (Glu1564-Lys1878) of SARS-COV-2(2019-nCoV) papain-like protease (Accession #YP_009725299.1) fused with an initial Met, a 6×His tag at the N-terminus. |
Purity | > 90% by SDS-PAGE. |
Endotoxin | < 1.0 EU/μg of the protein by LAL method. |
Formulation | Supplied as a 0.22 μm filtered solution in 20mM Tris, 20% Glycerol, 10mM β-Me,pH7.5.Contact us for customized product form or formulation. |
Species | SARS-CoV-2 |
Calculated MW | 36.6kDa |
Synonym | PLPro; PL-PRO; pp1a; Papain-like Protease; Replicase polyprotein 1a; ORF1a polyprotein; Plpro; COVID-19 |
---|---|
Expressed Host | E. coli |
Tag | N-His |
Storage | This product is stable at ≤ -70°C for up to 1 year from the date of receipt. For optimal storage, aliquot into smaller quantities after centrifugation and store at recommended temperature.Avoid repeated freeze-thaw cycles. |
---|
Submit your question about RP01274LQ below and we will get back to you within one business day.
Alternatively, call us at 888.754.5670.
* For research use only. Not for therapeutic or diagnostic purposes.